None listed
Conditions
Interventions
None listed
Sponsors
Department of Biotechnology
Medical Research Council UKRI
Eligibility
Inclusion criteria
Inclusion criteria: All South Asian men and women who are already participants of our existing population cohorts (LOLIPOP, iHealth-T2D, and GHRU surveillance studies) will be eligible to take part in this research. All study participants are >18 years old and have consented to recontact for research as part of enrolment to the respective population study.
Exclusion criteria
Exclusion criteria: Participants who have currently acute illness, or who are unable to provide consent will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the incidence of COVID-19 amongst participants of our established prospective population studies in India and the UK through serological testing, and linkage to electronic health registries. Timepoint: 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine the major risk factors for infection with SARS-CoV2 severe prolonged COVID-19 amongst South Asians To determine the social behavioral & environmental factors that underly susceptibility to COVID 19 in Asian populations and whether these known risk factors explain the high risk of COVID- 19 in Asians by comparing our results in South Asians with equivalent data for Europeans To report on vaccine hesitancy in South Asians and the main reasons for this Timepoint: 12 Months | — |
Countries
India, United Kingdom
Contacts
Public ContactDr R M Anjana
Max Superspeciality Hospital A Unit Of Devi Devi Foundation
Outcome results
None listed